Why hearing aids are excluded from Original Medicare

Medicare's exclusion of hearing aids isn't an oversight or a recent cost-cutting measure — it's written directly into the statute that created the program in 1965, alongside similar long-standing exclusions for routine dental and vision care. Hearing aids and the routine exams needed to fit them are explicitly carved out, regardless of how significantly hearing loss affects a beneficiary's daily life or safety.

This means the exclusion applies uniformly: it doesn't matter how severe the hearing loss is, whether a doctor recommends hearing aids, or how long you've been enrolled in Medicare. Even a Medigap policy doesn't help here, since Medigap only supplements costs that Medicare approves in the first place — with nothing underlying to supplement for hearing aids specifically, a Medigap plan has nothing to add.

It's worth understanding this alongside Medicare's broader original design: when the program launched, it was modeled closely on employer group insurance of that era, which itself rarely covered routine dental, vision, or hearing care. Decades of incremental legislation have since expanded Medicare in other directions — adding prescription drug coverage through Part D, for instance — without ever revisiting this specific original exclusion for hearing aids in a way that actually became law, despite repeated attempts.

What Medicare Part B actually covers

The exclusion is narrower than many people assume, and two real exceptions are worth knowing. First, Medicare Part B covers diagnostic hearing and balance exams when ordered by a physician specifically to determine whether an underlying medical condition is causing the hearing loss — not for the purpose of fitting hearing aids. These diagnostic exams follow Medicare's standard 80/20 cost-sharing structure after the Part B deductible.

Second, and less widely known: Medicare classifies cochlear implants and certain bone-anchored hearing devices as prosthetics rather than hearing aids, which means they can be covered when a beneficiary meets the specific medical criteria for that device. This is a genuinely important distinction — someone assuming "Medicare doesn't cover any hearing device" might not realize a cochlear implant, for the right clinical situation, falls into an entirely different coverage category.

The line between these categories comes down to how each device functions. A traditional hearing aid amplifies sound for an ear that still has some functioning capacity to process it. A cochlear implant instead bypasses damaged parts of the ear entirely, converting sound into electrical signals delivered directly to the auditory nerve — a fundamentally different mechanism that Medicare treats as restorative surgery and prosthetic replacement rather than routine amplification. This is why the two devices land in such different coverage categories despite both addressing hearing loss.

Medicare Advantage: the near-universal workaround

This is where the picture changes dramatically. Medicare Advantage plans must cover everything Original Medicare covers, but most go considerably further — industry analysis of 2026 plan data puts hearing benefit availability at roughly 95% to 98% of Medicare Advantage enrollees, making it one of the most commonly offered supplemental benefits alongside dental and vision. The most common structure is an annual allowance, commonly somewhere between $500 and $3,000, applied toward hearing aids purchased through the plan's network providers, often paired with a small number of free follow-up visits for adjustments.

Benefit specifics vary considerably between plans and change from year to year, so calling your specific plan's member services line and asking directly — what's the allowance, what's the copay structure, which providers are in-network — is worth doing rather than assuming last year's benefit still applies.

It's worth understanding the two most common benefit structures in a bit more detail, since they produce meaningfully different out-of-pocket outcomes. Some plans offer a flat dollar allowance applied toward whatever device you choose, with anything above that amount paid out of pocket. Others instead offer a fixed copay for a specific tier of device — commonly framed as something like a $500 or $700 copay for a mid-tier hearing aid regardless of its full retail price. Depending on which device you'd actually choose, one structure can meaningfully outperform the other, which is exactly why comparing the real numbers for your specific situation matters more than comparing headline allowance amounts alone.

This is exactly why timing matters this fall. Medicare's Annual Enrollment Period, running October 15 through December 7, 2026, is when beneficiaries choose or change their Medicare Advantage plan for the 2027 plan year specifically. Insurers file new benefit packages with CMS each year, and a hearing benefit's allowance, copay structure, or network can shift meaningfully from one plan year to the next — even under the same plan name. Reviewing your plan's Annual Notice of Change, which arrives before Open Enrollment begins, is the clearest way to confirm whether your 2027 hearing benefit still matches what you had in 2026.

The OTC hearing aid alternative

In October 2022, the FDA finalized a new category of over-the-counter hearing aids for adults with mild-to-moderate hearing loss, allowing purchase without a prescription, exam, or professional fitting. These are available at major retailers and online for roughly $200 to $3,000 per pair — a meaningful savings compared to the $3,500 to $7,500 typical cost of prescription-grade devices from a clinic.

Here's the nuance worth knowing before assuming this solves the cost problem entirely: most Medicare Advantage hearing benefits do not apply to OTC devices, since plan allowances typically cover only prescription-grade or plan-network devices specifically. OTC hearing aids are, however, a qualified expense under HSA and FSA accounts, so pre-tax dollars can offset the cost even without any insurance benefit applying.

OTC devices are specifically intended for mild-to-moderate hearing loss and rely on self-guided fitting rather than a professional evaluation, which makes them a reasonable fit for some beneficiaries but a poor substitute for others. Someone with more significant or complex hearing loss, or an underlying medical condition contributing to it, is generally better served starting with a proper diagnostic exam rather than assuming a self-fitted OTC device will adequately address their specific situation.

Medicaid and VA paths

For dual-eligible beneficiaries — those who qualify for both Medicare and Medicaid — state Medicaid programs may cover hearing aids, though this varies significantly: roughly 32 states currently cover hearing aids for adults, with benefit structures differing considerably between states. Contacting your state's Medicaid office, or a State Health Insurance Assistance Program (SHIP) counselor, is the most reliable way to confirm your specific state's current benefit.

Veterans with service-connected hearing loss can generally obtain hearing aids at no cost through VA benefits, a separate and often more comprehensive path than either Original Medicare or Medicare Advantage for veterans who qualify.

Dual-eligible beneficiaries specifically benefit from checking both programs together rather than assuming Medicare's exclusion is the final word, since Medicaid's rules operate entirely independently of Medicare's. A state that covers adult hearing aids through Medicaid effectively closes this gap for its dual-eligible residents in a way that no Medicare Advantage plan comparison alone would reveal, which is why confirming dual-eligible status and the specific state's Medicaid hearing benefit together is worth doing as a first step before assuming a Medicare Advantage plan switch is the only path forward.

A legislative update worth knowing heading into 2027

Several bills have been introduced in Congress over the years attempting to close Medicare's hearing aid gap. The most recent, the Medicare Hearing Aid Coverage Act (H.R. 500), proposed adding hearing aid coverage under Medicare Part B — but its own intended effective date was January 1, 2026, and that date has already passed without the bill being enacted. This is worth sitting with directly: not only has this coverage gap not closed, the specific legislative effort aimed at closing it has already missed its own deadline by the time 2027 planning begins.

Whether this bill, or a successor, eventually passes remains genuinely uncertain, and there's no indication of a new target date for the 2027 plan year specifically. The realistic planning approach for anyone shopping 2027 coverage is the same one that's applied for years: treat Medicare Advantage, OTC devices, Medicaid, and VA benefits as the actual paths to coverage, and treat federal legislation as something to watch rather than something to wait for.

Questions to ask before you choose

• Does my current or prospective Medicare Advantage plan include a hearing benefit, and what's the exact allowance?
• Does that allowance apply to OTC devices, or only prescription-grade devices through network providers?
• How many follow-up visits for adjustments are included at no extra cost?
• Am I a candidate for a cochlear implant or bone-anchored device that might be covered as a prosthetic?
• Does my state's Medicaid program cover hearing aids if I'm dual-eligible?
• Am I eligible for VA hearing aid benefits as a veteran with service-connected hearing loss?

Common questions about Medicare and hearing aids

Have a question that isn't answered below? Our full health insurance FAQ page covers more, and our related guides on cataract surgery and chiropractic care cover other specific Medicare coverage questions.